Medical therapies, comorbid conditions, and functional performance in people with peripheral artery disease enrolled in clinical trials between 2004 and 2021

Pooja Nayak; Tamar Polonsky; Lu Tian; Philip Greenland; Shujun Xu; Dongxue Zhang; Lihui Zhao; Michael H. Criqui; Melina R. Kibbe; Barbara Gladders; Philip Goodney; Karen Ho; Jack M. Guralnik; Mary M. McDermott

doi:10.1177/1358863X221145533

Medical therapies, comorbid conditions, and functional performance in people with peripheral artery disease enrolled in clinical trials between 2004 and 2021

Pooja Nayak, Tamar Polonsky, Lu Tian, Philip Greenland, Shujun Xu, Dongxue Zhang, Lihui Zhao, Michael H. Criqui, Melina R. Kibbe, Barbara Gladders, Philip Goodney, Karen Ho, Jack M. Guralnik, Mary M. McDermott

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	144-146
Number of pages	3
Journal	Vascular Medicine
Volume	28
Issue number	2
DOIs	https://doi.org/10.1177/1358863X221145533
State	Published - Apr 2023
Externally published	Yes

Keywords

exercise
functional assessment
intermittent claudication
opioids
peripheral artery disease (PAD)
randomized controlled trial (RCT)
statins

Access to Document

10.1177/1358863X221145533

Cite this

Nayak, P., Polonsky, T., Tian, L., Greenland, P., Xu, S., Zhang, D., Zhao, L., Criqui, M. H., Kibbe, M. R., Gladders, B., Goodney, P., Ho, K., Guralnik, J. M., & McDermott, M. M. (2023). Medical therapies, comorbid conditions, and functional performance in people with peripheral artery disease enrolled in clinical trials between 2004 and 2021. Vascular Medicine, 28(2), 144-146. https://doi.org/10.1177/1358863X221145533

@article{70c0e2d7a1c54f0088f66266221ea0ed,

title = "Medical therapies, comorbid conditions, and functional performance in people with peripheral artery disease enrolled in clinical trials between 2004 and 2021",

keywords = "exercise, functional assessment, intermittent claudication, opioids, peripheral artery disease (PAD), randomized controlled trial (RCT), statins",

author = "Pooja Nayak and Tamar Polonsky and Lu Tian and Philip Greenland and Shujun Xu and Dongxue Zhang and Lihui Zhao and Criqui, {Michael H.} and Kibbe, {Melina R.} and Barbara Gladders and Philip Goodney and Karen Ho and Guralnik, {Jack M.} and McDermott, {Mary M.}",

note = "Funding Information: The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: National Heart, Lung, and Blood Institute (R01HL073351, R01HL088589, R01HL107510, R01HL126117, R01HL131771), the National Institute on Aging (R21AG047510, R01AG070033, R01AG072335, R21AG056903, R21AG050897), and by the American Heart Association Strategically Focused Research Network on Peripheral Vascular Disease (18SFRN33900097, 18SFRN33970010). ",

year = "2023",

month = apr,

doi = "10.1177/1358863X221145533",

language = "English",

volume = "28",

pages = "144--146",

journal = "Vascular Medicine",

issn = "1358-863X",

publisher = "SAGE Publications Ltd",

number = "2",

}

Nayak, P, Polonsky, T, Tian, L, Greenland, P, Xu, S, Zhang, D, Zhao, L, Criqui, MH, Kibbe, MR, Gladders, B, Goodney, P, Ho, K, Guralnik, JM & McDermott, MM 2023, 'Medical therapies, comorbid conditions, and functional performance in people with peripheral artery disease enrolled in clinical trials between 2004 and 2021', Vascular Medicine, vol. 28, no. 2, pp. 144-146. https://doi.org/10.1177/1358863X221145533

TY - JOUR

T1 - Medical therapies, comorbid conditions, and functional performance in people with peripheral artery disease enrolled in clinical trials between 2004 and 2021

AU - Nayak, Pooja

AU - Polonsky, Tamar

AU - Tian, Lu

AU - Greenland, Philip

AU - Xu, Shujun

AU - Zhang, Dongxue

AU - Zhao, Lihui

AU - Criqui, Michael H.

AU - Kibbe, Melina R.

AU - Gladders, Barbara

AU - Goodney, Philip

AU - Ho, Karen

AU - Guralnik, Jack M.

AU - McDermott, Mary M.

N1 - Funding Information: The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: National Heart, Lung, and Blood Institute (R01HL073351, R01HL088589, R01HL107510, R01HL126117, R01HL131771), the National Institute on Aging (R21AG047510, R01AG070033, R01AG072335, R21AG056903, R21AG050897), and by the American Heart Association Strategically Focused Research Network on Peripheral Vascular Disease (18SFRN33900097, 18SFRN33970010).

PY - 2023/4

Y1 - 2023/4

KW - exercise

KW - functional assessment

KW - intermittent claudication

KW - opioids

KW - peripheral artery disease (PAD)

KW - randomized controlled trial (RCT)

KW - statins

UR - http://www.scopus.com/inward/record.url?scp=85152167891&partnerID=8YFLogxK

U2 - 10.1177/1358863X221145533

DO - 10.1177/1358863X221145533

M3 - Comment/debate

C2 - 36588397

AN - SCOPUS:85152167891

SN - 1358-863X

VL - 28

SP - 144

EP - 146

JO - Vascular Medicine

JF - Vascular Medicine

IS - 2

ER -